-----

Welcome to the December 2013 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, the global divide in pharmaceutical industry growth. Plus, the year in review for pharma companies and CDMOs, and CMOs. And the latest developments from the pharmaceutical industry in sustainability and global health.

Global Feature
The Global Divide in Pharma Industry Growth
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The next five years shows a continuing split in pharmaceutical industry growth between developed and emerging markets.
>> Read More

Global Feature
Pharma's Year in Review
Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management
Pharmaceutical Technology takes a look at the major deals and moves of 2013.
>> Read More

Outsourcing
Disposable Applications in Demand by Biopharma
Eric Langer,  president of BioPlan Associates
Interest in chromatography innovation continues to decline.
>> Read More

Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
>> Read More

Industry Events

For the full listing of calendar events, see the Calendar of Events page

Pharmaceutical Technology Webcast
Complex Parenteral Formulations for the Delivery of Peptides, Proteins, Nucleic Acids and Small Molecules
On-Demand Webcast
Progress in delivery science, manufacturing technologies, and commercialization successes are playing critical roles in advancing the development of complex parenteral formulations for new drug substances having a variety of formulation challenges. Unique formulation strategies and solutions are being investigated to extend the release or target peptides, proteins, nucleic acids, and small molecules for systemic, local or cellular delivery. This 60-minute webcast will provide insight on the delivery science and product development of complex parenteral formulations. Learn from leading industry experts on the formulation design and fabrication technologies used to make extended-release parenteral formulations for systemic and local delivery of peptides, proteins, and small molecules. Dosage forms to be discussed will include bioabsorbable microparticles and implants. Also, gain insight on siRNA drug delivery by examining advances in achieving human proof of concept for RNA interference (RNAi) and defining opportunities to develop nucleic acid-based medicines. Delivery approaches and related clinical applications will be examined for lipid nanoparticles, targeted conjugates, and polymer conjugates.
Registration information

Pharmaceutical Technology Webcast
Ensuring Global Regulatory Compliance for Product Registrations: Strategies for Risk Reduction and Operational Efficiency
On-Demand Webcast
Learn from industry and regulatory experts on how to create a robust quality management system for complying with country-based and regional-based regulatory requirements for product registration, product changes, and labeling changes. Gain insight into how to use automation for effectively tracking product registration and related correspondence to ensure global regulatory compliance.
Registration information

Pharmaceutical Technology Webcast
Achieving Raw-Material Transparency in the Pharmaceutical/ Biopharmaceutical Supply Chain
On-Demand Webcast
As regulatory demand increases on biopharmaceutical manufacturers to ensure the quality of the raw materials used for the manufacture of drug substances and formulation of finished drug products, these same demands filter back to suppliers. This 60-minute webcast will examine industry practice and use of regulatory guidance (FDA, EU, and ICH) for developing operational control and quality processes for mitigating risk in the pharmaceutical/biopharmaceutical supply chain. Learn from industry experts how to resolve the challenges toward achieving supply-chain transparency and its management as an ongoing concern.
Registration information

Pharmaceutical Technology Webcast
Risk Mitigation in API Manufacturing in Emerging Markets
On-Demand Webcast
Emerging markets are a crucial part of pharmaceutical companies’ growth strategy.  Pharmaceutical manufacturers must align their strategy with partners that can facilitate access to local markets, manage complex supply chains, meet global and national regulatory standards for quality, and secure production of APIs and intermediates for local as well as established markets in North America and Western Europe. This 60-minute webcast will provide insight and case-study analysis on the approaches taken by pharmaceutical companies to build their manufacturing networks in select emerging markets while mitigating risk in supplier selection and qualification to ensure reliable, consistent API supply.
Registration information